title: TRIF modulates TLR5-dependent responses by inducing proteolytic degradation of TLR5.
abstract: Proteolytic modification of pattern recognition receptors and their signaling adaptor molecules has recently emerged as an essential cellular event to regulate immune and inflammatory responses. Here we show that the TIR domain containing adaptor-inducing interferon-beta (TRIF), an adaptor molecule mediating TLR3 signaling and MyD88-independent signaling of TLR4, plays an inhibitory role in TLR5-elicited responses by inducing proteolytic degradation of TLR5. TRIF overexpression in human embryonic kidney (HEK293) and human colonic epithelial (NCM460) cells abolishes the cellular protein level of TLR5, whereas it does not alter TLR5 mRNA level. Thus, TRIF overexpression dramatically suppresses flagellin/TLR5-deriven NFkappaB activation in NCM460 cells. TRIF-induced TLR5 protein degradation is completely inhibited in the presence of pan-caspase inhibitor (benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone), whereas several specific inhibitors against cathepsin B, reactive oxygen species, or ubiquitin-mediated proteasome activity fail to suppress this degradation. These results indicate that TRIF-induced caspase activity causes TLR5 protein degradation. In addition, we identify that the C terminus of TRIF and extracellular domain of TLR5 are required for TRIF-induced TLR5 degradation. Furthermore, TRIF-induced proteolytic degradation is extended to TLR3, TLR6, TLR7, TLR8, TLR9, and TLR10, whereas the cellular level of TLR1, TLR2, and TLR4 is not affected by TRIF overexpression. These results suggest that, in addition to mediating TLR3- or TLR4-induced signaling as an adaptor molecule, TRIF can participate in proteolytic modification of certain members of TLRs to modulate the functionality of TLRs at post-translational level. Collectively, our findings propose a potential inhibitory role of TRIF at least in regulating host-microbial communication via TLR5 in colonic epithelial cells.
authors.affiliation: Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, USA.
authors.forename: Yoon Jeong
authors.initials: YJ
authors.lastname: Choi
authors.forename: Eunok
authors.initials: E
authors.lastname: Im
authors.forename: Charalabos
authors.initials: C
authors.lastname: Pothoulakis
authors.forename: Sang Hoon
authors.initials: SH
authors.lastname: Rhee
mesh_terms: D033942:Adaptor Proteins, Vesicular Transport / Q000502:physiology*; D000818:Animals; D020169:Caspases / Q000378:metabolism; D004847:Epithelial Cells / Q000166:cytology; D005786:Gene Expression Regulation; D006801:Humans; D007249:Inflammation; D051379:Mice; D053594:Myeloid Differentiation Factor 88 / Q000378:metabolism; D017434:Protein Structure, Tertiary; D012333:RNA, Messenger / Q000378:metabolism; D051198:Toll-Like Receptor 5 / Q000378:metabolism*
chemical_list: D033942:Adaptor Proteins, Vesicular Transport; D020169:Caspases; D053594:Myeloid Differentiation Factor 88; D012333:RNA, Messenger; D051198:Toll-Like Receptor 5; C507779:MYD88 protein, human; C507780:Myd88 protein, mouse; C476286:Ticam1 protein, mouse; C470409:TICAM1 protein, human; C495346:TLR5 protein, human
references.citation: J Biol Chem. 2008 Jun 27;283(26):18283-91
references.pmid: 18450748
references.citation: Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1518-23
references.pmid: 8643664
references.citation: J Biol Chem. 2004 Jun 11;279(24):25179-88
references.pmid: 15069060
references.citation: Curr Opin Immunol. 2008 Aug;20(4):420-5
references.pmid: 18625310
references.citation: J Immunol. 2005 May 15;174(10):6416-23
references.pmid: 15879143
references.citation: J Immunol. 2001 Aug 1;167(3):1609-16
references.pmid: 11466383
references.citation: Nat Immunol. 2008 Dec;9(12):1407-14
references.pmid: 18931679
references.citation: J Immunol. 2007 Oct 1;179(7):4808-20
references.pmid: 17878380
references.citation: Nat Immunol. 2003 Feb;4(2):161-7
references.pmid: 12539043
references.citation: Nat Rev Immunol. 2003 Jun;3(6):472-82
references.pmid: 12776207
references.citation: J Biol Chem. 2006 Jan 27;281(4):2095-103
references.pmid: 16306043
references.citation: Nat Immunol. 2008 Jul;9(7):769-76
references.pmid: 18516037
references.citation: Nat Immunol. 2004 May;5(5):503-7
references.pmid: 15064760
references.citation: Gastroenterology. 2008 Aug;135(2):518-28
references.pmid: 18538140
references.citation: Ann N Y Acad Sci. 2008 Nov;1143:1-20
references.pmid: 19076341
references.citation: Biochem Biophys Res Commun. 2008 Mar 14;367(3):693-9
references.pmid: 18166152
references.citation: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2992-7
references.pmid: 15710891
references.citation: J Immunol. 2005 Apr 15;174(8):4942-52
references.pmid: 15814722
references.citation: Inflamm Bowel Dis. 2008 Aug;14(8):1051-60
references.pmid: 18338780
references.citation: Annu Rev Pharmacol Toxicol. 2008;48:537-68
references.pmid: 18184106
references.citation: Cell Death Differ. 2008 Nov;15(11):1804-11
references.pmid: 18756281
references.citation: J Exp Med. 2009 Sep 28;206(10):2161-77
references.pmid: 19720838
references.citation: World J Gastroenterol. 2009 Oct 14;15(38):4745-52
references.pmid: 19824106
references.citation: Gastroenterol Clin North Am. 2006 Dec;35(4):883-93
references.pmid: 17129819
references.citation: J Biol Chem. 2006 Jul 7;281(27):18560-8
references.pmid: 16644730
references.citation: Nat Immunol. 2008 Apr;9(4):361-8
references.pmid: 18297073
references.citation: J Clin Invest. 2004 May;113(9):1296-306
references.pmid: 15124021
references.citation: Science. 2008 Apr 11;320(5873):226-30
references.pmid: 18403709
references.citation: J Biol Chem. 2004 Apr 9;279(15):15652-61
references.pmid: 14739303
references.citation: J Immunol. 2003 Feb 1;170(3):1406-15
references.pmid: 12538701
references.citation: Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1469-73
references.pmid: 17554134
references.citation: Nature. 2007 Oct 18;449(7164):819-26
references.pmid: 17943118
references.citation: J Biol Chem. 2000 Nov 3;275(44):34035-40
references.pmid: 10952994
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5862-7
references.pmid: 18391222
references.citation: J Biol Chem. 2006 Oct 13;281(41):31002-11
references.pmid: 16880211
references.citation: J Exp Med. 2007 Nov 26;204(12):2913-23
references.pmid: 17984303
references.citation: Nat Immunol. 2004 May;5(5):495-502
references.pmid: 15107846
references.citation: Hepatology. 2007 Apr;45(4):1014-24
references.pmid: 17385212
references.citation: Mol Cell. 1998 Aug;2(2):253-8
references.pmid: 9734363
references.citation: Genes Dev. 2006 Mar 1;20(5):537-42
references.pmid: 16510871
references.citation: Cytokine. 2008 Sep;43(3):342-9
references.pmid: 18706831
references.citation: J Immunol. 2008 Jun 1;180(11):7764-73
references.pmid: 18490781
references.citation: Immunol Rev. 2009 Jan;227(1):221-33
references.pmid: 19120487
references.citation: Immunology. 2004 Jul;112(3):428-36
references.pmid: 15196211
references.citation: Nature. 2005 Oct 20;437(7062):1167-72
references.pmid: 16177806
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13610-5
references.pmid: 16157881